Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Factor This
This Week in Cleantech
Factor This Policycast
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Factor This
Factor This Policycast
This Week in Cleantech
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DiaMedica Therapeutics Inc. - Common Stock
(NQ:
DMAC
)
6.715
-0.025 (-0.37%)
Streaming Delayed Price
Updated: 12:09 PM EDT, Aug 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about DiaMedica Therapeutics Inc. - Common Stock
< Previous
1
2
3
Next >
DiaMedica (DMAC) Q2 2026 Earnings Call Transcript
↗
August 17, 2026
ReMEDy2 stroke trial nears interim analysis with 85% enrollment complete.
Via
The Motley Fool
Topics
Earnings
DiaMedica Therapeutics Q2 Earnings Call Highlights
↗
August 11, 2026
DiaMedica Therapeutics (NASDAQ:DMAC) said its second-quarter progress centered on advancing DM199 across early-onset fetal growth restriction (FGR), preeclampsia and acute ischemic stroke, while the...
Via
MarketBeat
Topics
Earnings
DiaMedica (DMAC) Q4 2025 Earnings Transcript
↗
June 01, 2026
DiaMedica (DMAC) Q4 2025 Earnings Transcript
Via
The Motley Fool
Topics
Intellectual Property
DiaMedica Therapeutics (NASDAQ:DMAC) Posts Wider Q1 Loss but Clinical Catalysts Fuel Stock Resilience
↗
May 06, 2026
Via
Chartmill
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
Exploring DiaMedica Therapeutics's Earnings Expectations
↗
August 11, 2025
Via
Benzinga
DiaMedica (DMAC) Q1 2026 Earnings Transcript
↗
May 08, 2026
DiaMedica (DMAC) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Death
Top Wall Street Forecasters Revamp DiaMedica Therapeutics Expectations Ahead Of Q4 Earnings
↗
March 30, 2026
DiaMedica Therapeutics (NASDAQ: DMAC) will release Q4 earnings on March 30. Analysts expect a quarterly loss of 18 cents per share. Stock fell 0.9% on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
November 14, 2025
Via
Benzinga
DiaMedica Therapeutics Inc (NASDAQ:DMAC) Reports Q3 2025 Earnings and Clinical Progress
↗
November 12, 2025
DiaMedica reports Q3 2025 results, advancing DM199 for stroke and preeclampsia. The company has a cash runway into H2 2027 to fund clinical trials.
Via
Chartmill
Earnings Scheduled For November 13, 2024
↗
November 13, 2024
Via
Benzinga
Preview: DiaMedica Therapeutics's Earnings
↗
November 12, 2024
Via
Benzinga
Recap: DiaMedica Therapeutics Q4 Earnings
↗
March 19, 2024
Via
Benzinga
An Overview of DiaMedica Therapeutics's Earnings
↗
November 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 15, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 18, 2025
Via
Benzinga
DiaMedica Posts Narrower Loss in Q2
↗
August 12, 2025
Via
The Motley Fool
Topics
Intellectual Property
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Reports Q2 2025 Earnings: Narrower Loss and Promising Clinical Updates Drive Stock Surge
↗
August 12, 2025
DiaMedica Therapeutics reports Q2 2025 results with a narrower-than-expected loss, positive clinical updates, and strong cash position. Stock surges 19% post-earnings.
Via
Chartmill
Earnings Outlook For DiaMedica Therapeutics
↗
November 10, 2023
Via
Benzinga
Earnings Scheduled For August 12, 2025
↗
August 12, 2025
Via
Benzinga
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
Insights Ahead: DiaMedica Therapeutics's Quarterly Earnings
↗
May 12, 2025
Via
Benzinga
Why Ericsson Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
↗
April 15, 2025
Via
Benzinga
Earnings Scheduled For March 17, 2025
↗
March 17, 2025
Via
Benzinga
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
October 07, 2024
Via
Benzinga
DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q2 2024
↗
August 07, 2024
DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q1 2024
↗
May 08, 2024
DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
DMAC Stock Earnings: DiaMedica Therapeutics Meets EPS for Q4 2023
↗
March 19, 2024
DMAC stock results show that DiaMedica Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
October 25, 2023
Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning.
Via
InvestorPlace
Earnings Scheduled For November 13, 2023
↗
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
